Ciprofloxacin and levofloxacin resistance among methicillin-sensitive staphylococcus aureus isolates from keratitis and conjunctivitis

Aswad, 1990, Bacterial adherence to extended wear soft contact lenses, Ophthalmology, 97, 296, 10.1016/S0161-6420(90)32596-4 Gudmundsson, 1989, Factors influencing predilection and outcome of bacterial keratitis, Cornea, 8, 115, 10.1097/00003226-198906000-00007 Asbell, 1982, Ulcerative keratitis, Arch Ophthalmol, 100, 77, 10.1001/archopht.1982.01030030079005 Ormerod, 1987, Epidemiology of microbial keratitis in southern California, Ophthalmology, 94, 1322, 10.1016/S0161-6420(87)80019-2 Tuft, 2000, In vitro antibiotic resistance in bacterial keratitis in London, Br J Ophthalmol, 84, 687, 10.1136/bjo.84.7.687 Knauf, 1996, Susceptibility of corneal and conjunctival pathogens to ciprofloxacin, Cornea, 15, 66, 10.1097/00003226-199601000-00012 Alexandrakis, 2000, Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones, Ophthalmology, 107, 1497, 10.1016/S0161-6420(00)00179-2 Frohlich, 1999, Bacterial keratitis. Microbiological analysis as a principle for therapeutic recommendations, Ophthalmologe, 96, 459, 10.1007/s003470050437 Schaefer, 2001, Bacterial keratitis, Br J Ophthalmol, 85, 842, 10.1136/bjo.85.7.842 Tazawa, 1992, MRSA ocular infections, Nippon Rinsho, 50, 1122 Hackbarth, 1989, Methicillin-resistant staphylococci, Antimicrob Agents Chemother, 33, 995, 10.1128/AAC.33.7.995 Barza, 1991, Use of quinolones for treatment of ear and eye infections, Eur J Clin Microbiol Infect Dis, 10, 296, 10.1007/BF01967003 Neu, 1991, Microbiologic aspects of fluoroquinolones, Am J Ophthalmol, 112, 15S Baum, 2000, The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis, Cornea, 19, 659, 10.1097/00003226-200009000-00011 Blumberg, 1991, Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus, J Infect Dis, 163, 1279, 10.1093/infdis/163.6.1279 Maple, 1989, Ciprofloxacin resistance in methicillin and gentamicin-resistant Staphylococcus aureus, Eur J Clin Microbiol Infect Dis, 8, 622, 10.1007/BF01968141 Shalit, 1989, Widespread quinolone resistance among methicillin resistant Staphylococcus aureus isolates in a general hospital, Antimicrob Agents Chemother, 33, 593, 10.1128/AAC.33.4.593 Daum, 1990, Increasing resistance of Staphylococcus aureus to ciprofloxacin, Antimicrob Agents Chemother, 34, 1862, 10.1128/AAC.34.9.1862 George, 1990, Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK, Antimicrob Chemother, 26, 145, 10.1093/jac/26.suppl_F.145 Ball, 1990, Emerging resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus, J Antimicrob Chemother, 26, 165, 10.1093/jac/26.suppl_F.165 Liesegang, 1980, Spectrum of microbial keratitis in South Florida, Am J Ophthalmol, 90, 38, 10.1016/S0002-9394(14)75075-5 Alfonso, 1986, Ulcerative keratitis associated with contact lens wear, Am J Ophthalmol, 101, 429, 10.1016/0002-9394(86)90641-0 Kowalski, 2001, An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeroginosa, Ophthalmology, 108, 1826, 10.1016/S0161-6420(01)00724-2 Isaacs, 1988, Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus, Lancet, 2, 843, 10.1016/S0140-6736(88)92799-7 Raviglione, 1990, Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital, Antimicrob Agents Chemother, 34, 2050, 10.1128/AAC.34.11.2050 Marangon FB, Miller D, Alfonso EC. Impact of prior therapy on the recovery and frequency of ocular pathogens. Cornea, In press. Wilson, 2001, Linezolid, Hosp Med, 62, 682 French, 2001, Linezolid, Int J Clin Pract, 55, 59, 10.1111/j.1742-1241.2001.tb10975.x Tsiodras, 2001, Linezolid resistance in a clinical isolate of Staphylococcus aureus, Lancet, 358, 207, 10.1016/S0140-6736(01)05410-1 Lawyer, 2001, Linezolid and reversible myelosuppression, JAMA, 286, 1974 Dajes, 2000, Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit, Invest Ophthalmol Vis Sci, 41, 1432 Mather, 2002, Fourth generation fluoroquinolones, Am J Ophthalmol, 133, 463, 10.1016/S0002-9394(02)01334-X Malathum, 1999, In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria, Diagn Microbiol Infect Dis, 35, 127, 10.1016/S0732-8893(99)00065-6 Blondeau, 2000, Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms, Int J Antimicrob Agents, 14, 45, 10.1016/S0924-8579(99)00143-0 Abb, 2002, In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus, Diagn Microbiol Infect Dis, 43, 319, 10.1016/S0732-8893(02)00407-8